Panel discussion on...
Pet Supplements
Francesca Susca, DVM, Ph.D.1,
Cassandre Dujardin2
1. Global Category Manager Pet, Lallemand Animal Nutrition
2. Product Manager, Lallemand Health Solutions


Member of AgroFOOD Industry Hi Tech's Scientific Advisory Board


Pet Supplements Market Trends and Insights
The pet supplement category is entering a period of rapid evolution, driven by two powerful forces: pet humanization and the growing focus on healthy aging. As companion animals live longer and owners increasingly view them as family, the conversation around aging is shifting from treating problems after they appear to preventing them before they surface. This shift is fueling demand for supplements and functional ingredients that support mobility, maintain muscle mass, enhance cognition, and preserve overall vitality throughout a pet’s lifespan.
Yet this fastgrowing market also presents challenges. The category is more competitive than ever, and pet owners now want visible functional benefits, credible science, and clear differentiation. Brands capable of integrating functional ingredients as a true nutritional pillar, backed by robust evidence and transparent communication, will be the ones that stand out.
At the same time, the biggest opportunities lie in the revolution happening in microbial science. Advances in microbiome research are reshaping our understanding of how gut health influences
immunity, skin and coat condition, oral health, cognition, and emotional wellbeing. Probiotics continue to play a leading role, while postbiotics, valued for their stability, safety, and formulation flexibility, are opening the door to a new generation of targeted, condition specific solutions. Together, these microbial based ingredients allow manufacturers to elevate their value proposition and drive the next wave of innovation in pet supplements.
1B) Species specific research is essential when selecting and developing active ingredients for pets because dogs and cats have physiological, metabolic, immune, and microbiome characteristics that differ significantly from humans. Animal scientific models, such as mice can provide useful mechanistic insights that help guide the early stages of ingredient selection.
That said, differences in digestion, safety thresholds, microbiota composition, and dose–response relationships mean that efficacy, safety, and claims must always be validated in the target species. In short, animal scientific models can guide early understanding and help identify strains of interest, but species-specific research remains essential for responsible and credible pet product development.
1C) The humanization of pets has undoubtedly encouraged consumers to pay closer attention to ingredient quality, scientific evidence, and overall pet wellbeing. However, it also brings a risk: pets do not metabolize ingredients the same way humans do, and benefits seen in human studies do not automatically translate to the same outcomes in animals.
In short, humanization raises awareness but without proper education, it can blur the boundaries between science based benefits and human driven assumptions. Helping consumers understand what is truly validated in pets and what remains marketing borrowed from the human wellness world is key to maintaining trust and ensuring responsible use of supplements.
1D) For functional ingredients in pet supplements, the key quality parameters are those that ensure reliable, repeatable performance. Ingredients must be standardized and consistent batch to batch, so the active components deliver the same effect every time. They also need to be bioavailable for dogs and cats, ensuring the actives can be effectively absorbed and utilized. Equally important is that these ingredients are easy to incorporate into different supplement formats (chews, powders, liquids) without causing formulation issues. Finally, proven stability throughout processing and shelf life is essential to ensure the promised benefits remain intact in the finished product.
1I) Owner reported outcomes are for sure less objective than veterinary assessments, but they remain essential because they reflect what truly happens in real life. They capture how pets behave and feel in their home environment and, importantly, how owners perceive the supplement’s benefits: a perception that strongly drives their willingness to purchase and continue using the product.
Today, in home studies are even more powerful: the ability to collect and analyze fecal samples or other biological samples allows researchers to combine a more commercial, real world approach with solid scientific validation. This integrated model (owner perception plus measurable biological changes) provides a realistic and highly relevant way to evaluate the true performance of pet supplements.
In this Panel Discussion, several prominent companies within the food and nutraceutical ingredient industry have been invited to discuss about drivers and barriers of healthy lifestyle, focusing on global and regional consumer trends, scientific achievements, emerging delivery formats, use of AI technologies and the implementation of the United Nations sustainability goals.
Panelists
References and notes
- Schunck, M. , Louton, H. and Oesser, S. (2017) The Effectiveness of Specific Collagen Peptides on Osteoarthritis in Dogs-Impact on Metabolic Processes in Canine Chondrocytes. Open Journal of Animal Sciences, 7, 254-266. doi: 10.4236/ojas.2017.73020.
- Koivisto et al., 2014; Siebert et al., 2010
- The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients—A translational large animal model for a nutritional therapy option
Dobenecker B, Böswald LF, Reese S, Steigmeier-Raith S, Trillig L, et al. (2024) The oral intake of specific Bioactive Collagen Peptides (BCP) improves gait and quality of life in canine osteoarthritis patients—A translational large animal model for a nutritional therapy option. PLOS ONE 19(9): e0308378. https://doi.org/10.1371/journal.pone.0308378
Questions
1.
2.
3.
4.
Ingredients companies - clinical data
A) What are the main scientific gaps that still exist in PET supplement development compared to human dietary supplements?
B) How important is species-specific research when selecting and developing active ingredients for pets? Can human data ever be sufficient?
C) Is the humanization of pets helping consumers make better-informed choices, or does it risk creating unrealistic expectations about supplement performance?
D) From an ingredient supplier’s perspective, which quality parameters (standardization, bioavailability, purity) are most critical for PET applications?
E) How are trends such as “clean label,” sustainability, and transparency influencing pet owners’ purchasing decisions in the PET supplement space?
F) What type of clinical evidence should realistically be expected to support PET supplement claims today?
G) Which types of claims are most likely to be misunderstood by consumers, and how can this risk be reduced through clearer substantiation and labeling?
H) What are the main methodological challenges in conducting clinical trials for companion animals, and how can they be addressed?
I) How reliable are owner-reported outcomes compared to veterinary assessments, and how should they be integrated into study design?
L) Have you noticed an increasing trend in the use of one (or more) ingredients for pet supplements formulated to promote healthy ageing?
Formulation
A) What are the biggest formulation challenges in PET supplements, particularly regarding palatability, stability, and dosing accuracy?
B) How do formulation choices (e.g., chews, powders, liquids) influence compliance and consistent use from a consumer perspective?
C) Do you see a shift toward simpler, single-ingredient formulations, or are multi-active blends still the dominant approach? Why?
D) How do species differences (dogs vs cats, size, age) influence formulation strategies?
E) Omega 3 alternatives for pet nutrition and sustainability: how do the innovative omega-3s for pet food stack up against their traditional fishy counterparts?
Regulation
A) How do regulatory frameworks for PET supplements differ between the EU and the US, and what challenges do these differences create for global brands?
B) Which types of claims represent the highest regulatory risk today, and which are more likely to be acceptable if properly substantiated?
C) Do you expect regulatory oversight of PET supplements to become stricter in the coming years? Why or why not?
D) What role should veterinarians play in guiding pet owners’ choices regarding PET supplements, and how can trust between brands, vets, and consumers be strengthened?
Open questions
A) Looking ahead 5–10 years, what will be the key factors determining the credibility and long-term success of the PET supplements sector?
B) In your view, what single change—scientific, regulatory, or educational—would most improve consumer trust in PET supplements over the next decade?
References and notes










